Qiming Venture Partners VIII-HC, L.P.
10% Owner

Qiming Venture Partners VIII-HC, L.P. insider trades: Alamar Biosciences (ALMR) stock sales

10% Owner, Alamar Biosciences Last trade Nov 3, 2026 8 Form 4 filings
$44.6M
Sold, last 12 months
7 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2026
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Qiming Venture Partners VIII-HC, L.P. reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 3, 2026ALMR↓ Sell$3.3M
Nov 2, 2026ALMR↓ Sell$5.7M
Oct 28, 2026ALMR↓ Sell$6.0M
Oct 26, 2026ALMR↓ Sell$8.6M
Oct 22, 2026ALMR↓ Sell$10.3M
Oct 20, 2026ALMR↓ Sell$5.9M
Oct 16, 2026ALMR↓ Sell$4.8M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ALMR insiders

Open-market trades in the last 12 months

About Qiming Venture Partners VIII-HC, L.P.'s insider trades

Qiming Venture Partners VIII-HC, L.P. is a 10% owner of Alamar Biosciences (ALMR). Since Oct 16, 2026, it has reported no open-market purchases and 7 sales worth $44.6M on SEC Form 4. In the last 12 months: 7 sales ($44.6M).

Its filings also include conversions (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.